Yanan Zhang

This inventor holds 24 USPTO granted patents and 4 published patent applications and 5 EPO patents, primarily in Neuropeptide Modulators. Top assignees: Medtronic Minimed, Inc., Research Triangle Institute, San Meditech (Huzhou) Co., Ltd.. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yanan Zhang. Retrieved from https://idiyas.com/inventor/yanan-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 4)

% Patents Active = 83.3

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 3.1

ph-index = 7

Forward Citations = 1,239(Granted Patents)

Location History:

Northridge, CA (US) (2011)
Valencia, CA (US) (2005 - 2014)
Apex, NC (US) (2015 - 2023)

Company Filing History:

12 out of 1,267

Medtronic Minimed, Inc.

patents

11 out of 359

Research Triangle Institute

patents

1 out of 1

San Meditech (Huzhou) Co., Ltd.

patent

Years Active: 2005-2026

Loading Chart...

Areas of Expertise:

Orexin Receptor Agonists

Neuropeptide FF Receptor Modulators

CB1 Allosteric Modulators

Bioavailability

Diphenyl Purine Derivatives

NPSR Antagonists

Cannabinoid Receptor 1 Antagonists

Implantable Sensors

Molded Protein Matrix

Sensing Apparatus

Sensor Recalibration

Biosensor

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12729178 - Arylsulfonamides as orexin receptor agonists (2026-09-08),

2. 12390446 - Proline-based neuropeptide FF receptor modulators (2025-08-19),

3. 12358869 - Diarylureas as CB1 allosteric modulators (2025-07-15),

4. 11826350 - Proline-based neuropeptide FF receptor modulators (2023-11-28),

5. 11491136 - Proline-based neuropeptide FF receptor modulators (2022-11-08),

6. 11084781 - Diarylureas as CB1 allosteric modulators (2021-08-10),

7. 10696677 - Diaryl purine derivatives with improved bioavailability (2020-06-30),

8. 9458160 - Peripherally restricted diphenyl purine derivatives (2016-10-04),

9. 9187480 - Peripherally restricted diphenyl purine derivatives (2015-11-17),

10. 9150582 - Composition and method for neuropeptide S receptor (NPSR) antagonists (2015-10-06),

11. 9133128 - Pyrazole derivatives as cannabinoid receptor 1 antagonists (2015-09-15),

12. 8777852 - System and method for sensor recalibration (2014-07-15),

13. 8352011 - Blood contacting sensor (2013-01-08),

14. 8187851 - Method of forming a molded protein matrix for a sensor (2012-05-29),

15. 8137927 - Molded protein material in form of pellet for sensor (2012-03-20),

Title: Yanan Zhang: Pioneer in Neuropeptide Research and Allosteric Modulators

Introduction

Yanan Zhang is an innovative inventor based in Valencia, California, recognized for his contributions to the fields of neuropeptide research and pharmacology. With a remarkable portfolio of 22 patents, Zhang has been at the forefront of developing novel compounds and methods aimed at addressing various health disorders.

Latest Patents

Among Yanan Zhang's latest patents are two significant innovations:

1. **Proline-based neuropeptide FF receptor modulators** - This invention presents neuropeptide FF receptor modulators built on a proline scaffold. These compounds demonstrate NPFF receptor potencies in the nanomolar range, offering antagonistic selectivity for the NPFF1 receptor. The methods and compositions developed through this patent are targeted towards pharmacotherapies that can effectively influence conditions associated with neuropeptide FF receptors.

2. **Diarylureas as CB1 allosteric modulators** - In this patent, Zhang introduces novel diarylurea derivatives that act as allosteric modulators of the CB1 receptor. These compounds have potential therapeutic applications for managing diseases and conditions mediated by the CB1 receptor, showcasing Zhang’s innovative approach to drug development.

Career Highlights

Yanan Zhang's career includes significant tenures at reputable organizations such as Medtronic Minimed, Inc. and Research Triangle Institute. His roles within these companies have enabled him to further his research and development efforts, leading to the creation of many impactful inventions. His work has not only advanced scientific knowledge but has also contributed to potential therapeutic solutions in medicine.

Collaborations

Throughout his career, Yanan Zhang has collaborated with various talented colleagues, including Rajiv Shah and Bahar Reghabi. These collaborations have fostered a dynamic exchange of ideas and expertise, enhancing the quality and depth of Zhang's research projects.

Conclusion

Yanan Zhang’s innovative contributions to neuropeptide research and drug modulation have positioned him as a noteworthy inventor in the biomedical field. With 22 patents to his name, his ongoing commitment to discovering novel therapeutics continues to pave the way for advancements in medical science. Zhang exemplifies the impact that dedicated inventors can have in shaping the future of health and medicine.

Profile summary based on public USPTO records.